United-Guardian, Inc. (NASDAQ:UG) Short Interest Update

United-Guardian, Inc. (NASDAQ:UGGet Free Report) was the target of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 19,800 shares, an increase of 57.1% from the October 15th total of 12,600 shares. Based on an average daily volume of 20,100 shares, the short-interest ratio is currently 1.0 days. Approximately 0.7% of the shares of the company are short sold.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on United-Guardian in a research report on Monday, August 26th. They issued a “buy” rating on the stock.

Check Out Our Latest Report on United-Guardian

United-Guardian Price Performance

United-Guardian stock opened at $9.55 on Friday. The business’s fifty day moving average is $13.58 and its two-hundred day moving average is $11.50. United-Guardian has a 52 week low of $6.75 and a 52 week high of $16.25.

United-Guardian (NASDAQ:UGGet Free Report) last posted its quarterly earnings data on Friday, November 8th. The company reported $0.19 EPS for the quarter. United-Guardian had a return on equity of 30.13% and a net margin of 28.30%. The company had revenue of $3.06 million for the quarter.

Hedge Funds Weigh In On United-Guardian

Several large investors have recently made changes to their positions in UG. Rodgers Brothers Inc. lifted its stake in shares of United-Guardian by 5.0% during the first quarter. Rodgers Brothers Inc. now owns 100,100 shares of the company’s stock valued at $766,000 after acquiring an additional 4,750 shares during the period. Renaissance Technologies LLC lifted its stake in United-Guardian by 1.1% in the second quarter. Renaissance Technologies LLC now owns 187,563 shares of the company’s stock valued at $1,677,000 after buying an additional 2,100 shares during the period. Finally, Essex Investment Management Co. LLC acquired a new position in United-Guardian in the third quarter valued at about $126,000. Institutional investors and hedge funds own 23.16% of the company’s stock.

About United-Guardian

(Get Free Report)

United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.

Recommended Stories

Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.